000 | 01135 a2200337 4500 | ||
---|---|---|---|
005 | 20250513215024.0 | ||
264 | 0 | _c20000929 | |
008 | 200009s 0 0 eng d | ||
022 | _a1784-3227 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHong, Z | |
245 | 0 | 0 |
_aDevelopment of novel anti-HCV therapies: HCV protease, helicase, and polymerase as therapeutic targets. _h[electronic resource] |
260 |
_bActa gastro-enterologica Belgica _c |
||
300 |
_a210-2 p. _bdigital |
||
500 | _aPublication Type: Congress; Review | ||
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aDNA Helicases _xdrug effects |
650 | 0 | 4 |
_aDNA, Complementary _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepacivirus _xdrug effects |
650 | 0 | 4 |
_aHepatitis C _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProtease Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 |
_aViral Nonstructural Proteins _xdrug effects |
700 | 1 | _aStandring, D N | |
700 | 1 | _aBaroudy, B | |
700 | 1 | _aLau, J Y | |
773 | 0 |
_tActa gastro-enterologica Belgica _gvol. 63 _gno. 2 _gp. 210-2 |
|
999 |
_c10874664 _d10874664 |